by MM360 Staff | Jun 6, 2025 | Myeloma News
Source: Pharmacy Times articles Never taking a break does more harm than good. Read More
by MM360 Staff | Jun 6, 2025 | Uncategorized
Source: CureToday articles Patients with oligometastatic lung cancer may live longer with surgery, but experts stress the need for multidisciplinary evaluation to guide treatment choices. Read More
by MM360 Staff | Jun 6, 2025 | Myeloma News
Source: Pharmacy Times articles A panelist discusses how emerging research in non–small cell lung cancer (NSCLC) is focused on determining the most effective neoadjuvant/adjuvant approaches combining chemotherapy with immunotherapy, addressing tumor heterogeneity...
by MM360 Staff | Jun 6, 2025 | Myeloma News
Source: Pharmacy Times articles Panelists discuss how evolving treatment pathways at Emory Healthcare, including earlier use of emerging therapies and off-label combination treatments, are shaping the management of chronic graft-vs-host disease (cGVHD), with an...
by MM360 Staff | Jun 6, 2025 | Publications
Clin Lymphoma Myeloma Leuk. 2025 May 14:S2152-2650(25)00159-4. doi: 10.1016/j.clml.2025.05.007. Online ahead of print. ABSTRACT BACKGROUND: The standard treatment for newly diagnosed, transplant-eligible multiple myeloma (NDMM) patients typically involves triplet...
